Andrew Halpert

Current VP of R&D at Reprieve Cardio, following its spin-off from RenalGuard. As former RenalGuard CTO, designed and built multiple generations of the device, led clinical trials, and CE approval. Began career supporting medical device innovation at the Coridea medical device incubator, the original home of RenalGuard.